Circulating microRNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke

Journal of Human Hypertension

Volumn 28, Issue 5, 2014, Pages 288-291

  Li, W Y ^a   Jin, J ^a   Chen, J ^a   Guo, Y ^a   Tang, J ^b   Tan, S ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

biomarkers; circulating microRNA; hemorrhagic stroke; hypertension related stroke; ischemic stroke

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA;

ARTERIAL PRESSURE; BIOSYNTHESIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; GENE CONTROL; GENE EXPRESSION; HUMAN; HYPERTENSION; NON INVASIVE PROCEDURE; NONHUMAN; PATHOGENESIS; REVIEW; RNA DEGRADATION; BLOOD; CEREBRAL HEMORRHAGE; COMPLICATION; EARLY DIAGNOSIS; STROKE;

BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; EARLY DIAGNOSIS; HUMANS; HYPERTENSION; MICRORNAS; STROKE;

EID: 84898541370     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.94     Document Type: Review

References (48)

1. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 2007; 6(5): 456-464.
2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125(1): 188-197.
3. Cerrato P, Grasso M, Imperiale D, Priano L, Baima C, Giraudo M et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis 2004; 18(2): 154-159.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-297.
5. Gan CS, Wang CW, Tan KS. Circulatory microRNA-145 expression is increased in cerebral ischemia. Genet Mol Res 2012; 11(1): 147-152.
6. Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC et al. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL- 6-Stat3 pathway. Hepatology 2013; 58(1): 158-170.
7. Yang H, Fang F, Chang R, Yang L. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma. Hepatology 2013; 58(1): 205-217.
8. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31(6): 659-666.
9. Nagalingam RS, Sundaresan NR, Gupta MP, Geenen D, Solaro RJ, Gupta M. A cardiac enriched microRNA, miR-378 blocks cardiac hypertrophy by targeting Rassignaling. J Biol Chem 2013; 288(16): 11216-11232.
10. Dickinson BA, Semus HM, Montgomery RL, Stack C, Latimer PA, Lewton SM et al. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur J Heart Fail 2013; 15(6): 650-659.
11. Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 2011; 124(2): 175-184.
12. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18(10): 997-1006.
13. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3(9): e3148.
14. Krupinski J, Slevin M. Emerging molecular targets for brain repair after stroke. Stroke Res Treat 2013; 2013: 473416.
15. Qureshi IA, Mehler MF. The emerging role of epigenetics in stroke: II. RNA regulatory circuitry. Arch Neurol 2010; 67(12): 1435-1441.
16. Koutsis G, Siasos G, Spengos K. The emerging role of microRNA in stroke. Curr Top Med Chem 2013; 13(13): 1573-1588.
17. Wu P, Zuo X, Ji A. Stroke-induced microRNAs: the potential therapeutic role for stroke. Exp Ther Med 2012; 3(4): 571-576.
18. Veglio F, Paglieri C, Rabbia F, Bisbocci D, Bergui M, Cerrato P. Hypertension and cerebrovascular damage. Atherosclerosis 2009; 205(2): 331-341.
19. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31(7): 1281-1357.
20. Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R. Blood pressure variability and multiple organ damage in primary hypertension. J Hum Hypertens 2013; 27(11): 663-670.
21. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet 2009; 373(9675): 1632-1644.
22. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis 2009; 27(5): 493-501.
23. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105(30): 10513-10518.
24. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 2011; 80(2): 193-208.
25. Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA. Cell 2013; 153(3): 516-519.
26. Behm-Ansmant I, Rehwinkel J, Izaurralde E. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol 2006; 71: 523-530.
27. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79: 351-379.
28. Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 2009; 21(3): 452-460.
29. Djuranovic S, Nahvi A, Green R. A parsimonious model for gene regulation by miRNAs. Science 2011; 331(6017): 550-553.
30. Stevens H, Jakobs C, de Jager AE, Cunningham RT, Korf J. Neurone-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke. Eur J Clin Invest 1999; 29(1): 6-11.
31. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30(6): 1190-1195.
32. Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P et al. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens 2011; 24(2): 241-246.
33. Ouyang YB, Lu Y, Yue S, Xu LJ, Xiong XX, White RE et al. miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol Dis 2012; 45(1): 555-563.
34. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008; 39(3): 959-966.
35. Liu DZ, Tian Y, Ander BP, Xu H, Stamova BS, Zhan X et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 2010; 30(1): 92-101.
36. Selvamani A, Sathyan P, Miranda RC, Sohrabji F. An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS One 2012; 7(2): e32662.
37. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK et al. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009; 55(11): 1977-1983.
38. Weng H, Shen C, Hirokawa G, Ji X, Takahashi R, Shimada K et al. Plasma miR-124 as a biomarker for cerebral infarction. Biomed Res 2011; 32(2): 135-141.
39. Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, Wang CW et al. Expression profile of MicroRNAs in young stroke patients. PLoS One 2009; 4(11): e7689.
40. Chen J, Yang T, Yu H, Sun K, Shi Y, Song W et al. A functional variant in the 3'-UTR of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microRNA 211. Hum Mol Genet 2010; 19(12): 2524-2533.
41. Bai Y, Wang L, Sun L, Ye P, Hui R. Circulating microRNA-26a: potential predictors and therapeutic targets for non-hypertensive intracerebral hemorrhage. Med Hypotheses 2011; 77(4): 488-490.
42. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011; 226(4): 1035-1043.
43. Zheng HW, Wang YL, Lin JX, Li N, Zhao XQ, Liu GF et al. Circulating MicroRNAs as potential risk biomarkers for hematoma enlargement after intracerebral hemorrhage. CNS Neurosci Ther 2012; 18(12): 1003-1011.
44. Guo D, Liu J, Wang W, Hao F, Sun X, Wu X et al. Alteration in abundance and compartmentalization of inflammation-related miRNAs in plasma after intracerebral hemorrhage. Stroke 2013; 44(6): 1739-1742.
45. Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Bjorkqvist M. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum Mol Genet 2011; 20(11): 2225-2237.
46. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor proteincleaving enzyme 1. J Neurosci 2008; 28(5): 1213-1223.
47. Ciesla M, Skrzypek K, Kozakowska M, Loboda A, Jozkowicz A, Dulak J. MicroRNAs as biomarkers of disease onset. Anal Bioanal Chem 2011; 401(7): 2051-2061.
48. Heggermont WA, Heymans S. MicroRNAs are involved in end-organ damage during hypertension. Hypertension 2012; 60(5): 1088-1093.